Sermorelin + GHRP-2 [Peptide]

Description

Sermorelin + GHRP-2 [Peptide]

The product is only intended for laboratory research use and not for human consumption. 

Available quantities:

• 10 mg

Product Information 

Handling and Storage of Sermorelin + GHRP-2 Peptide

The peptide compound should be stored in a cool and dry place to maximize its stability. For Sermorelin + GHRP-2 lyophilized peptides, it is recommended to store them in the refrigerator between 2°C and 8°C (36°F–46°F) in an airtight container. 

Lab user exposure: 

• Avoid prolonged or repeated exposure.
• Avoid inhalation.
• Avoid contact with eyes or skin.
• Handle inside standard laboratory containment.
• Use gloves, a lab coat, and protective eyewear.

Redissolving:

• Can be reconstituted in sterile distilled water or suitable buffer solutions.
• A small amount of DMSO or 0.1% TFA may be used to test or improve solubility.
• Mix gently, avoid high-temperature heating. 

Choice of container and precautions:

• Low-binding sterile polypropylene to prevent adsorption
• Borosilicate glass vials to prevent adsorption in the glass walls
• Avoid polystyrene
• Avoid lab plastic containers

Overview of the Sermorelin + GHRP-2 Peptide

Sermorelin and GHRP-2 (Growth Hormone–Releasing Peptide-2) are two different peptides often combined to stimulate the body’s natural production of growth hormone (GH). They do not replace GH directly; instead, they signal the pituitary gland to release more of your own growth hormone.

Sermorelin is a synthetic form of GHRH (Growth Hormone–Releasing Hormone). GHRP-2 is a Growth Hormone Secretagogue, meaning it triggers GH release through a different pathway (ghrelin receptor activation).

Working Mechanism of Sermorelin + GHRP-2 Peptide

• Sermorelin and GHRP-2 are extensively studied together due to their complementary roles in stimulating growth hormone release in experimental models. 
• Preclinical studies suggest that GHRP-2 helps inhibit somatostatin, a hormone that suppresses growth hormone production in laboratory models. Sermorelin, on the other hand, stimulates the pituitary gland to release more growth hormone in research models.

TFA Salt Form 

Sermorelin and GHRP-2 are provided in their TFA salt form. Residual trifluoroacetate content is typically up to 10% w/w. It depends on the final formulation and lyophilization conditions. The exact TFA content can be confirmed by batch-specific COA.

Disclaimer
Sermorelin and GHRP-2  peptides are intended exclusively for laboratory research purposes. RCDbio products are not intended to diagnose, treat, cure, or prevent any disease. The Food and Drug Administration has not evaluated the statements on our website. By purchasing, you agree to our Terms and Conditions.